Terms: = Head and neck cancer AND NSD1, FLJ44628, 64324, ENSG00000165671, Q96L73, FLJ22263, DKFZp666C163, ARA267, STO, SOTOS AND Treatment
13 results:
1. nsd1 promotes esophageal cancer tumorigenesis via HIF1α signaling.
He F; Xiao H; Cai Y; Zhang N
Cell Biol Toxicol; 2023 Aug; 39(4):1835-1850. PubMed ID: 36522543
[TBL] [Abstract] [Full Text] [Related]
2. Understanding the Roles of the NSD Protein Methyltransferases in head and neck Squamous Cell Carcinoma.
Murali M; Saloura V
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
[TBL] [Abstract] [Full Text] [Related]
3. Detecting head and neck lymph node metastases with white light reflectance spectroscopy; a pilot study.
Bugter O; Aaboubout Y; Algoe M; de Bruijn HS; Keereweer S; Sewnaik A; Monserez DA; Koljenović S; Hardillo JAU; Robinson DJ; Baatenburg de Jong RJ
Oral Oncol; 2021 Dec; 123():105627. PubMed ID: 34826688
[TBL] [Abstract] [Full Text] [Related]
4. Hyperactivation of MEK/ERK pathway by Ca
Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
[TBL] [Abstract] [Full Text] [Related]
5. Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in head and neck Squamous Cell Carcinoma.
Khorani K; Schwaerzler J; Burkart S; Kurth I; Holzinger D; Flechtenmacher C; Plinkert PK; Zaoui K; Hess J
Mol Cancer Res; 2021 Oct; 19(10):1676-1687. PubMed ID: 34285085
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Profiling Associated with Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2)-Mediated Carcinogenesis in Gastric cancer.
Najar MA; Modi PK; Ramesh P; Sidransky D; Gowda H; Prasad TSK; Chatterjee A
J Proteome Res; 2021 May; 20(5):2687-2703. PubMed ID: 33844560
[TBL] [Abstract] [Full Text] [Related]
7. All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Kim HAJ; Zeng PYF; Shaikh MH; Mundi N; Ghasemi F; Di Gravio E; Khan H; MacNeil D; Khan MI; Patel K; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
Oral Oncol; 2021 May; 116():105260. PubMed ID: 33725617
[TBL] [Abstract] [Full Text] [Related]
8. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma.
Liang S; Li C; Gao Z; Li J; Zhao H; Yu J; Meng X
Int Immunopharmacol; 2021 Jan; 90():107178. PubMed ID: 33218939
[TBL] [Abstract] [Full Text] [Related]
9. Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO sto 0217).
Tintelnot J; Goekkurt E; Binder M; Thuss-Patience P; Lorenzen S; Knorrenschild JR; Kretzschmar A; Ettrich T; Lindig U; Jacobasch L; Pink D; Al-Batran SE; Hinke A; Hegewisch-Becker S; Nilsson S; Bokemeyer C; Stein A
BMC Cancer; 2020 Jun; 20(1):503. PubMed ID: 32487035
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
[TBL] [Abstract] [Full Text] [Related]
11. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract] [Full Text] [Related]
12. nsd1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Peri S; Izumchenko E; Schubert AD; Slifker MJ; Ruth K; Serebriiskii IG; Guo T; Burtness BA; Mehra R; Ross EA; Sidransky D; Golemis EA
Nat Commun; 2017 Nov; 8(1):1772. PubMed ID: 29176703
[TBL] [Abstract] [Full Text] [Related]
13. Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.
Korkeila EA; Salminen T; Kallio R; Mikkola M; Auvinen P; Pyrhönen S; Ristamäki R
Support Care Cancer; 2017 Sep; 25(9):2771-2777. PubMed ID: 28424889
[TBL] [Abstract] [Full Text] [Related]
